News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
724,794 Results
Type
Article (41663)
Company Profile (272)
Press Release (682849)
Multimedia
Podcasts (81)
Webinars (18)
Section
Business (205464)
Career Advice (2040)
Deals (35585)
Drug Delivery (111)
Drug Development (81532)
Employer Resources (173)
FDA (16451)
Job Trends (15010)
News (347482)
Policy (32830)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2614)
Academic (1)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49873)
ALS (170)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (310)
Approvals (16717)
Artificial intelligence (517)
Autoimmune disease (155)
Automation (39)
Bankruptcy (363)
Best Places to Work (11664)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (178)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (639)
Cancer (4809)
Cardiovascular disease (399)
Career advice (1722)
Career pathing (37)
CAR-T (283)
CDC (44)
Celiac Disease (2)
Cell therapy (745)
Cervical cancer (36)
Clinical research (69655)
Collaboration (1705)
Company closure (4)
Compensation (1162)
Complete response letters (56)
COVID-19 (2727)
CRISPR (90)
C-suite (848)
Cystic fibrosis (143)
Data (6231)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (501)
Diagnostics (6718)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (185)
Drug shortages (28)
Duchenne muscular dystrophy (231)
Earnings (90266)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117668)
Executive appointments (976)
FDA (19568)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1478)
Gene editing (196)
Generative AI (43)
Gene therapy (597)
GLP-1 (966)
Government (4688)
Grass and pollen (6)
Guidances (383)
Healthcare (18904)
HIV (58)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (249)
Immuno-oncology (57)
Indications (110)
Infectious disease (3000)
Inflammatory bowel disease (188)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (249)
Interviews (318)
IPO (16658)
IRA (50)
Job creations (3679)
Job search strategy (1441)
JPM (57)
Kidney cancer (16)
Labor market (87)
Layoffs (550)
Leadership (33)
Legal (7967)
Liver cancer (92)
Longevity (14)
Lung cancer (650)
Lymphoma (376)
Machine learning (42)
Management (59)
Manufacturing (794)
MASH (164)
Medical device (13802)
Medtech (13855)
Mergers & acquisitions (19998)
Metabolic disorders (1268)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (317)
Neuropsychiatric disorders (88)
Neuroscience (2902)
Neurotech (1)
NextGen: Class of 2026 (6539)
Non-profit (4543)
Now hiring (67)
Obesity (594)
Opinion (259)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (227)
Parkinson's disease (282)
Partnered (33)
Patents (495)
Patient recruitment (491)
Peanut (56)
People (59181)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21738)
Phase 2 (30647)
Phase 3 (22829)
Pipeline (5287)
Policy (284)
Postmarket research (2569)
Preclinical (9227)
Press Release (68)
Prostate cancer (237)
Psychedelics (48)
Radiopharmaceuticals (280)
Rare diseases (834)
Real estate (6015)
Recruiting (70)
Regulatory (24550)
Reports (53)
Research institute (2430)
Resumes & cover letters (354)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (241)
Series B (191)
Service/supplier (11)
Sickle cell disease (96)
Special edition (22)
Spinal muscular atrophy (158)
Sponsored (42)
Startups (3638)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (85)
The Weekly (54)
Vaccines (1011)
Venture capital (88)
Weight loss (380)
Women's health (91)
Worklife (18)
Date
Today (34)
Last 7 days (542)
Last 30 days (2042)
Last 365 days (29824)
2026 (3478)
2025 (30221)
2024 (35260)
2023 (40139)
2022 (51245)
2021 (55810)
2020 (54208)
2019 (46687)
2018 (35176)
2017 (32278)
2016 (31673)
2015 (37787)
2014 (31481)
2013 (26557)
2012 (28755)
2011 (29438)
2010 (27552)
Location
Africa (741)
Alabama (84)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39464)
Australia (6446)
California (11296)
Canada (3288)
China (1101)
Colorado (477)
Connecticut (476)
Delaware (337)
Europe (85047)
Florida (1690)
Georgia (357)
Hawaii (3)
Idaho (61)
Illinois (861)
India (65)
Indiana (521)
Iowa (22)
Japan (430)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1382)
Massachusetts (8096)
Michigan (324)
Minnesota (628)
Mississippi (6)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3006)
New Mexico (28)
New York (2980)
North Carolina (1450)
North Dakota (8)
Northern California (5518)
Ohio (333)
Oklahoma (21)
Oregon (41)
Pennsylvania (2279)
Puerto Rico (24)
Rhode Island (48)
South America (1117)
South Carolina (66)
South Dakota (1)
Southern California (4399)
Tennessee (176)
Texas (1744)
United States (40053)
Utah (335)
Vermont (1)
Virginia (263)
Washington D.C. (81)
Washington State (920)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
724,794 Results for "aruna biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Aruna Bio to Participate in Upcoming Investor Conferences
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at upcoming investor conferences.
March 18, 2024
·
1 min read
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Business
Aruna BIO Announces Appointment of Lynn Swann to its Board of Directors
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative conditions, announced the appointment of Lynn Swann to its Board of Directors.
June 3, 2024
·
2 min read
BioMidwest
Aruna BIO Establishes Stroke Advisory Board to Advance Lead Program, AB126 into the Clinic
Aruna Bio, Inc., a leader in neural exosome-based therapeutics for the treatment of neurodegenerative diseases, is pleased to announce the formation of its Stroke Advisory Board.
March 4, 2024
·
4 min read
Genetown
Aruna Bio to Participate in the BIO Investor Forum in October 2023
Aruna Bio, Inc. today announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the BIO Investor Forum being held October 17-18, 2023, in San Francisco, CA.
October 10, 2023
·
1 min read
Press Releases
Lifecore Biomedical to be Added to Nasdaq Biotech Index
December 18, 2025
·
1 min read
Press Releases
Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery
February 9, 2026
·
6 min read
Press Releases
Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic Fixation
February 12, 2026
·
3 min read
Press Releases
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
June 23, 2025
·
11 min read
Genetown
Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication
Aruna Bio, Inc., a pioneer in the development of neural exosome-based therapeutics for the treatment of neurodegenerative diseases, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of lead program, AB126.
January 16, 2024
·
3 min read
1 of 72,480
Next
